Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat
出版年份 2019 全文链接
标题
Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat
作者
关键词
-
出版物
Current Infectious Disease Reports
Volume 21, Issue 12, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-16
DOI
10.1007/s11908-019-0706-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Antibody Dependent Enhancement of Acinetobacter baumannii Infection in a Mouse Pneumonia Model
- (2019) Shun Xin Wang-Lin et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)
- (2019) Ana C Gales et al. Open Forum Infectious Diseases
- Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii
- (2019) Tianshui Niu et al. Antimicrobial Resistance and Infection Control
- Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections
- (2019) Khalid Eljaaly et al. DRUGS
- Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
- (2019) George G. Zhanel et al. DRUGS
- Identification of a novel plasmid carries mcr-4.3 in Acinetobacter baumannii from China
- (2019) Furong Ma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug‐Resistant Gram‐Negative Bacterial Infections in Solid Organ Transplant Recipients – Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
- (2019) Stephanie M. Pouch et al. CLINICAL TRANSPLANTATION
- Evaluation of the ratio of the estimated area under the concentration-time curve to minimum inhibitory concentration (estimated AUIC) as a predictor of the outcome for tigecycline treatment for pneumonia due to multidrug-resistant bacteria in an intensive care unit
- (2019) Ying Xu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Implications of Bacteriophage- and Bacteriophage Component-Based Therapies For The Clinical Microbiology Laboratory
- (2019) Katherine M. Caflisch et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Advances in Diagnostic Testing that Impact Infection Prevention and Antimicrobial Stewardship Programs
- (2019) Kaede V. Sullivan Current Infectious Disease Reports
- Specific and Selective Bacteriophages in the Fight against Multidrug-resistant Acinetobacter baumannii
- (2019) Natalia Bagińska et al. VIROLOGICA SINICA
- In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from United States Hospitals and Comparative Activity of Aminoglycosides against Carbapenem-Resistant Enterobacteriaceae and Isolates Carrying Carbapenemase Genes
- (2018) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis
- (2018) Lynn E. Connolly et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An Antibiotic Stewardship Program Blueprint for Optimizing Verigene BC-GN within an Institution: a Tale of Two Cities
- (2018) Jason M. Pogue et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program
- (2018) Michael A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Epidemiology and Mechanism of Sulbactam Resistance in Acinetobacter baumannii Isolates with Diverse Genetic Backgrounds in China
- (2018) Yunxing Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii
- (2018) T. Amat et al. CLINICAL MICROBIOLOGY AND INFECTION
- Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii
- (2018) C.-A. Liang et al. CLINICAL MICROBIOLOGY AND INFECTION
- Activity of TP-6076 against carbapenem-resistant Acinetobacter baumannii isolates collected from inpatients in Greek hospitals
- (2018) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii
- (2018) Harald Seifert et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†
- (2018) Peter M Hawkey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fitness cost of mcr-1-mediated polymyxin resistance in Klebsiella pneumoniae
- (2018) Sue C Nang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
- (2018) Mical Paul et al. LANCET INFECTIOUS DISEASES
- Salvage tigecycline in high risk febrile neutropenic patients with hematological malignancies: a prospective multicenter study
- (2018) Xin-Ping Zhou et al. LEUKEMIA & LYMPHOMA
- Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection
- (2018) Stephanie LaVergne et al. Open Forum Infectious Diseases
- DETECTION OF AMINOGLYCOSIDE AND QUINOLONE RESISTANCE GENES AND EVALUATION OF POLYMYXIN B SUSCEPTIBILITY PROFILE IN ACINETOBACTER BAUMANNII CLINICAL ISOLATES IN TEHRAN, IRAN DURING 2015-2016
- (2018) Mohsen Heidary Mediterranean Journal of Hematology and Infectious Diseases
- Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult Subjects
- (2018) Keith A. Rodvold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities
- (2018) Muhammad Asif et al. Infection and Drug Resistance
- OXA-23 Is a Prevalent Mechanism Contributing to Sulbactam Resistance in Diverse Acinetobacter baumannii Clinical Strains
- (2018) Yunxing Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment outcomes of colistin and carbapenem-resistant Acinetobacter baumannii infections: an exploratory subgroup analysis of a randomized clinical trial
- (2018) Yaakov Dickstein et al. CLINICAL INFECTIOUS DISEASES
- Detection and prevalence of carbapenem-resistant Gram-negative bacteria among European laboratories part of the COMBACTE network: a COMBACTE LAB-Net survey
- (2018) T Kostyanev et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial
- (2018) Simon Portsmouth et al. LANCET INFECTIOUS DISEASES
- 1377. Omadacycline In Vitro Activity Against a Molecularly Characterized Collection of Clinical Isolates with Known Tetracycline Resistance Mechanisms
- (2018) Rodrigo E Mendes et al. Open Forum Infectious Diseases
- International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
- (2017) Antoni Torres et al. EUROPEAN RESPIRATORY JOURNAL
- Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis
- (2017) Kirati Kengkla et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity
- (2017) Justin R. Lenhard et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of sulbactam for the treatment of Acinetobacter baumannii complex infection: A systematic review and meta-analysis
- (2017) Haojun Chen et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis
- (2017) Travis B Nielsen et al. JOURNAL OF INFECTIOUS DISEASES
- First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate
- (2017) Mohamed H. Al-Agamy et al. Microbial Drug Resistance
- The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection
- (2017) John E. Mazuski et al. Surgical Infections
- ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii
- (2017) Thomas F. Durand-Réville et al. Nature Microbiology
- A New Take on an Old Remedy: Generating Antibodies against Multidrug-Resistant Gram-Negative Bacteria in a Postantibiotic World
- (2017) Michael P. Motley et al. mSphere
- Safety and Pharmacokinetics (PK) in Humans of Intravenous ETX2514, a β-lactamase Inhibitor (BLI) which Broadly Inhibits Ambler Class A, C, and D β-lactamases
- (2017) Jason Lickliter et al. Open Forum Infectious Diseases
- Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Cefiderocol, a Parenteral Siderophore Cephalosporin, for Dose Adjustment Based on Renal Function
- (2016) Takayuki Katsube et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
- (2016) Andre C. Kalil et al. CLINICAL INFECTIOUS DISEASES
- Inhaled Antibiotics for Gram-Negative Respiratory Infections
- (2016) Eric Wenzler et al. CLINICAL MICROBIOLOGY REVIEWS
- Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia
- (2016) Li-Yang Hsu et al. CLINICAL MICROBIOLOGY REVIEWS
- Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages
- (2016) Agata Anna Cisek et al. CURRENT MICROBIOLOGY
- Impact of rapid identification of Acinetobacter Baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with pneumonia and/or bacteremia
- (2016) Eric Wenzler et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Strategies for the treatment of polymyxin B-resistant Acinetobacter baumannii infections
- (2016) Thatiany Cevallos Menegucci et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis
- (2016) Wentao Ni et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Detection of the plasmid-mediated quinolone resistance determinants in clinical isolates ofAcinetobacter baumanniiin China
- (2016) Haifei Yang et al. JOURNAL OF CHEMOTHERAPY
- Tetracycline Antibiotics and Resistance
- (2016) Trudy H. Grossman Cold Spring Harbor Perspectives in Medicine
- Application of Bacteriophage-containing Aerosol against Nosocomial Transmission of Carbapenem-Resistant Acinetobacter baumannii in an Intensive Care Unit
- (2016) Yu-Huai Ho et al. PLoS One
- Structure-Activity Relationship of the Aminomethylcyclines and the Discovery of Omadacycline
- (2015) Laura Honeyman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii?
- (2015) Cristina García-Salguero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Ribosomal S10 Protein Is a General Target for Decreased Tigecycline Susceptibility
- (2015) Kathryn Beabout et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A PmrB-Regulated Deacetylase Required for Lipid A Modification and Polymyxin Resistance in Acinetobacter baumannii
- (2015) Chui-Yoke Chin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Task force on management and prevention of Acinetobacter baumannii infections in the ICU
- (2015) José Garnacho-Montero et al. INTENSIVE CARE MEDICINE
- Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
- (2015) Mario Tumbarello et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population pharmacokinetic–pharmacodynamic target attainment analysis of sulbactam in patients with impaired renal function: Dosing considerations for Acinetobacter baumannii infections
- (2015) Yuta Yokoyama et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City
- (2014) Marie Abdallah et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Outcomes of Hospital-Acquired Infection with Acinetobacter nosocomialis and Acinetobacter pittii
- (2014) Sarunyou Chusri et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
- (2014) George L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tetracycline antibiotics and resistance mechanisms
- (2014) Fabian Nguyen et al. BIOLOGICAL CHEMISTRY
- Bad Bugs Need Old Drugs: A Stewardship Program's Evaluation of Minocycline for Multidrug-Resistant Acinetobacter baumannii Infections
- (2014) Debra A. Goff et al. CLINICAL INFECTIOUS DISEASES
- Carbapenem-Resistance in Gram-Negative Bacilli and Intravenous Minocycline: An Antimicrobial Stewardship Approach at the Detroit Medical Center
- (2014) Jason M. Pogue et al. CLINICAL INFECTIOUS DISEASES
- Review of Rapid Diagnostic Tests Used by Antimicrobial Stewardship Programs
- (2014) Karri A. Bauer et al. CLINICAL INFECTIOUS DISEASES
- OXA -Lactamases
- (2014) B. A. Evans et al. CLINICAL MICROBIOLOGY REVIEWS
- Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections
- (2014) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Systematic Review and Meta-Analysis ofIn VitroSynergy of Polymyxins and Carbapenems
- (2013) Oren Zusman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
- (2013) J. A. Sutcliffe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase
- (2013) Q. Chen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- TEM-1 -lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii
- (2013) L. Krizova et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Metallo-β-lactamase structure and function
- (2012) Timothy Palzkill Annals of the New York Academy of Sciences
- Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic
- (2012) Trudy H. Grossman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ThepmrCABOperon Mediates Polymyxin Resistance inAcinetobacter baumanniiATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid A
- (2011) Luis A. Arroyo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory System
- (2011) Alejandro Beceiro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Overexpression of Resistance-Nodulation-Cell Division Pump AdeFGH Confers Multidrug Resistance in Acinetobacter baumannii
- (2010) S. Coyne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efflux-Mediated Antibiotic Resistance inAcinetobacterspp.
- (2010) Sébastien Coyne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
- (2010) J. H. Moffatt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- GES Extended-Spectrum -Lactamases in Acinetobacter baumannii Isolates in Belgium
- (2010) P. Bogaerts et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
- (2010) Nicola C. Gordon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tetracycline Susceptibility Testing and Resistance Genes in Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Complex from a U.S. Military Hospital
- (2009) K. S. Akers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Detection of KPC in Acinetobacter spp. in Puerto Rico
- (2009) I. E. Robledo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System
- (2009) M. D. Adams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Acinetobacter baumannii: Emergence of a Successful Pathogen
- (2008) A. Y. Peleg et al. CLINICAL MICROBIOLOGY REVIEWS
- First report of qnrB-producing Enterobacter cloacae and qnrA-producing Acinetobacter baumannii recovered from Algerian hospitals
- (2007) Abdelaziz Touati et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search